BR112018007918A2 - vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal. - Google Patents

vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal.

Info

Publication number
BR112018007918A2
BR112018007918A2 BR112018007918A BR112018007918A BR112018007918A2 BR 112018007918 A2 BR112018007918 A2 BR 112018007918A2 BR 112018007918 A BR112018007918 A BR 112018007918A BR 112018007918 A BR112018007918 A BR 112018007918A BR 112018007918 A2 BR112018007918 A2 BR 112018007918A2
Authority
BR
Brazil
Prior art keywords
animal
lawsonia intracellularis
vaccine
protect
intracellularis antigen
Prior art date
Application number
BR112018007918A
Other languages
English (en)
Inventor
Arnoldus Christiaan Jacobs Antonius
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112018007918A2 publication Critical patent/BR112018007918A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

a presente invenção refere-se a uma vacina compreendendo antígeno de lawsonia intracellularis inativada para administração intradérmica a um animal que tem anticorpos derivados maternalmente direcionados contra lawsonia intracellularis, para uso em um método para proteger o animal contra um distúrbio decorrente de uma infecção por lawsonia intracellularis.
BR112018007918A 2015-10-22 2016-10-21 vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal. BR112018007918A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15190969 2015-10-22
PCT/EP2016/075382 WO2017068126A1 (en) 2015-10-22 2016-10-21 A vaccine to protect an mda positive animal against a disorder arising from an infection with lawsonia intracellularis

Publications (1)

Publication Number Publication Date
BR112018007918A2 true BR112018007918A2 (pt) 2018-10-30

Family

ID=54360034

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018007918A BR112018007918A2 (pt) 2015-10-22 2016-10-21 vacina, uso de antígeno de lawsonia intracellularis inativada, e, método para proteger um animal.

Country Status (12)

Country Link
US (1) US20180303924A1 (pt)
EP (1) EP3365001B1 (pt)
JP (1) JP6906511B2 (pt)
KR (1) KR20180064418A (pt)
CN (1) CN108135990A (pt)
BR (1) BR112018007918A2 (pt)
DK (1) DK3365001T3 (pt)
ES (1) ES2924034T3 (pt)
HU (1) HUE059657T2 (pt)
PL (1) PL3365001T3 (pt)
RU (2) RU2020140678A (pt)
WO (1) WO2017068126A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
UA96923C2 (ru) * 2005-07-15 2011-12-26 Берингер Ингельхайм Ветмедика, Инк. Вакцина на основе lawsonia и способы ее применения
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
BR112016012435A8 (pt) * 2013-12-03 2018-01-30 Intervet Int Bv vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
JP6488304B2 (ja) * 2013-12-03 2019-03-20 インターベット インターナショナル ベー． フェー． ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅ ｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン

Also Published As

Publication number Publication date
US20180303924A1 (en) 2018-10-25
ES2924034T3 (es) 2022-10-04
RU2018118175A (ru) 2019-11-25
DK3365001T3 (da) 2022-08-22
RU2020140678A (ru) 2021-01-27
JP6906511B2 (ja) 2021-07-21
RU2020140678A3 (pt) 2021-02-26
HUE059657T2 (hu) 2022-12-28
JP2018531265A (ja) 2018-10-25
WO2017068126A1 (en) 2017-04-27
PL3365001T3 (pl) 2022-08-08
EP3365001B1 (en) 2022-06-29
RU2018118175A3 (pt) 2020-01-30
CN108135990A (zh) 2018-06-08
KR20180064418A (ko) 2018-06-14
EP3365001A1 (en) 2018-08-29

Similar Documents

Publication Publication Date Title
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
EA201691993A1 (ru) Вакцина к вирусу эпидемической диареи свиней
BR112014024533A2 (pt) vacina contra mycoplasma hyopneumoniae
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
BR112017000519A2 (pt) "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica"
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
BR112016006192A2 (pt) composição de vacina de divergente de pcv2b e métodos de uso
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
BR112021019028A2 (pt) Uma vacina para proteção contra streptococcus suis
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
BR112018010679A8 (pt) métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina
BR112015021523A2 (pt) composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa
BR112017013286A2 (pt) composto de isoxazolina, e, uso de um composto de isoxazolina.
BR112017005272A2 (pt) uso de cisteamina no tratamento de infecções causadas por leveduras/bolores
BR112015032388A2 (pt) métodos e composições para as vacinas contra o vírus da dengue
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
BR112016015078A2 (pt) método para prevenir ou tratar infecção por vírus influenza a h7n9, uso do anticorpo e composição farmacêutica
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
BR112017025316A2 (pt) estratégia de vacina baseada em nanopartículas contra o vírus da gripe suína
EA201792593A1 (ru) Пестивирусные вакцины против врожденного тремора

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]